
ELZA gives CXL update @ University Eye Clinic Basel
ELZA founder Farhad Hafezi presents the latest CXL research findings from his research group at the Eye Clinic of the University of Basel

ELZA founder Farhad Hafezi presents the latest CXL research findings from his research group at the Eye Clinic of the University of Basel

Das USC Roski Eye Institute hält ein Symposium Refraktive Chirurgie mit nationalen und internationalen Rednern. Der ELZA-Gründer Farhad Hafezi spricht über Cross-Linking Technologie.

Eye World Interview with Dr. Sabine Kling and Prof. Farhad Hafezi

The textbook “Corneal Cross-Linking” by Farhad Hafezi and J. Bradley Randleman is the oldest and most complete textbook on cross-linking technology and was recently translated into Chinese by Prof. Qinmei Wang and Dr. Shihao Chen from the University of Wenzhou, China

Prof. Hafezi from the ELZA Institute is an invited speaker at RSOS 2017. Intense discussions about recent advances in therapeutic refractive laser surgery, Dry Eye and keratoconus.

The ELZA Institute gave a series of keynote lectures on corneal cross-linking at the Narayana Nathralana keratoconus meeting, along with respected friends and colleagues Prof. Eberhard Spoerl, Prof. Michael Belin and Dr. Rajesh Fogla

ELZA and CME for ophthalmologists in the Middle East: The Focal Points, edited by the Noor Ophthalmic Research Center in Teheran, represent the most important CME program for ophthalmologists in Iran

The ELZA member Prof. Farhad Hafezi speaks on modern cross-linking therapy and his CXL experience that started in 2001 at the DOG Berlin 2016

Prof. Hafezi is international invited speaker at the Al Watany Ophthalmology Summit in Cairo, Egypt. The summit is co-organized by ARVO, the Association for Research in Vision and Ophthalmology

The International CXL Experts’ Meeting 2016 Zurich, organized by the Light for Sight Foundation, is an independent forum to unite expert clinicians and researchers in the field of corneal cross-linking.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.